Free Trial
CVE:HIV

HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis

HIVE Blockchain Technologies logo

About HIVE Blockchain Technologies Stock (CVE:HIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive HIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.

HIV Stock News Headlines

B. Riley Has Bearish Estimate for CVE:HIV Q4 Earnings
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

HIV Stock Analysis - Frequently Asked Questions

HIVE Blockchain Technologies Ltd. (CVE:HIV) posted its earnings results on Tuesday, November, 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.04.

Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HIVE Blockchain Technologies investors own include ProShares Bitcoin ETF (BITO), Meta Platforms (META), Broadcom (AVGO), MARA (MARA), NVIDIA (NVDA), Riot Platforms (RIOT) and Shopify (SHOP).

Company Calendar

Last Earnings
11/12/2024
Today
5/03/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Services – Management, Public Relations, Consulting
Sub-Industry
Business Services
Current Symbol
CVE:HIV
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (CVE:HIV) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners